Mabwell (Shanghai) Bioscience Co., Ltd.

¥22.08As of Sun 8 Nov 2026, 12:00 UTC
SSE:688062Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR 1.30%
Div yield —
ROE (114.69%)
Biotechnology
Beta (5Y) 0.64
PE TTM —
TSR TTM (53.50%)
Mkt cap ¥9.525B
ROIC (14.62%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥22
1.89%
(11.64%)
Hold 4|11|7|5|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.23
0.22
0.23
0.25
11.52%
7.71%
8.42%
19.01%
Revenue¥M
921.4
901.9
945.9
939.6
8.88%
5.29%
7.69%
4.10%
Peers (US$1.428B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
10.95
(0.027)
(0.024)
EBIT/Intx
2.777
0.450
0.530
Own earn%
(23.41)
268.31
268.24
Sh yield%
27.29
41.54
39.30
Owners
Insiders/Inst%
2.11
31.57
Short interest%
1.92
SBC / revenue%
4.78
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
22–27
$1 testx
0.0
Incr. ROIC%
6